Pfizer reports high efficacy for adult RSV vaccine in early trial
But doubts remain about duration of protection and ability to prevent lower respiratory tract disease.
Tag: Pharmaceutical
Roche study flop marks yet another Alzheimer’s drug setback
Investigational agent crenezumab failed to slow or prevent disease progression, company says.
GP charged with drug offences after manufacturing his own novel painkiller
Dr Clive Stack is facing drugs charges, including unlawfully supplying a narcotic substance.
Biologics work equally well for active Crohn’s: head-to-head study
The first data comparing adalimumab and ustekinumab suggest similar efficacy and safety.
Investigational drug reduces symptom severity in postpartum depression: trial
The manufacturers of zuranolone plan to file for US approval early next year.
Experimental drug halts lung deterioration in IPF
The benefits are seen with the oral preferential PDE4 inhibitor regardless of background antifibrotic use, researchers found.
Effervescent tablet subsidised for eosinophilic oesophagitis
The formulation increases the length of time damaged mucosa is exposed to a topical steroid.
Romosozumab ‘safe and effective’ in women with osteoporosis and CKD
A post-hoc analysis shows the biologic reduced fracture risk with similar adverse event rates across a range of renal function levels.
Immunosuppressant gets PBAC nod for ulcerative colitis
Listing would benefit patients who don't respond or are intolerant of other therapies.
From a gout mainstay to novel autoimmune therapies: The hunt for a long COVID panacea
Scientists are looking at repurposing existing treatments as well as new agents targeting fatigue and inflammation.
